Financials Sernova Toronto S.E.

Stocks

Market Closed - Toronto S.E. 23:18:34 18/09/2026 +04			5-day change	1st Jan Change
0.1050 ^CAD	0.00%		-25.00%	-19.23%

09-11	Sernova Biotherapeutics Inc Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2026	CI
09-08	Seraxis Holdings, Inc. entered into a definitive agreement to acquire Sernova Biotherapeutics Inc in a merger of equals, reverse merger transaction.	CI

Fiscal Period: October	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	-	-	-	-	-	-	2.5	127.8
Change	-	-	-	-	-	-	-	5,012%
EBITDA	-6.669	-24.31	-40.06	-31.12	-14.68	-	-	-
Change	-	-264.56%	-64.75%	22.3%	52.83%	-	-	-
EBIT ¹	-6.937	-24.75	-40.5	-31.66	-15.02	-9.2	-11.9	-18.9
Change	-	-256.86%	-63.62%	21.82%	52.55%	38.76%	-29.35%	-58.82%
Interest Paid ¹	-0.0584	-	-0.0321	-0.5869	-0.7548	-2.2	-2	-2
Earnings before Tax (EBT) ¹	-6.966	-24.42	-39	-32.19	-15.73	-11.4	-13.9	-20.9
Change	-	-250.59%	-59.69%	17.47%	51.11%	27.55%	-21.93%	-50.36%
Net income ¹	-6.966	-24.42	-39	-32.19	-15.74	-11.3	-13.9	-20.9
Change	-	-250.59%	-59.69%	17.45%	51.1%	28.22%	-23.01%	-50.36%
Announcement Date	14/02/22	26/01/23	29/01/24	23/12/24	19/12/25	-	-	-

¹CAD in Million

Estimates

Fiscal Period: October	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-2.373	-5.363	-4.822	-5.794	-8.334	-8.501	-9.699	-10.16	-	-9.923	-9.696	-6.991	-4.513	-	-	-	-	-	-	-	-
Change	-	-126%	10.09%	-20.16%	-43.83%	-2.01%	-14.09%	-4.79%	-	-	2.29%	27.89%	35.45%	-	-	-	-	-	-	-	-
EBIT ¹	-	-	-	-	-8.452	-8.608	-9.808	-	-	-	-	-	-	-	-	-	-	-	-	-2.118	-2.4
Change	-	-	-	-	-	-1.85%	-13.93%	-	-	-	-	-	-	-	-	-	-	-	-	-	-13.32%
Charge d'intérêts ¹	-	-	-	-	-	-	-	-	-0.00605	-	-0.0212	-0.3555	-	-	-0.2387	-0.5417	0.2606	-0.4771	-	-0.2602	-0.5
Earnings before Tax (EBT) ¹	-	-	-	-5.831	-8.21	-8.015	-9.347	-9.932	-11.7	-	-	-7.537	-4.961	-	-3.74	-4.053	-2.252	-2.406	-3.228	-2.574	-3.865
Change	-	-	-	-	-40.79%	2.38%	-16.61%	-6.26%	-17.84%	-	-	-	34.18%	-	-	-8.35%	44.43%	-6.85%	-34.14%	20.25%	-50.14%
Net income ¹	-	-	-	-5.831	-8.21	-8.015	-9.347	-9.932	-11.7	-	-	-7.537	-4.968	-5.695	-3.777	-4.074	-2.197	-2.334	-3.228	-2.529	-3.865
Change	-	-	-	-	-40.79%	2.38%	-16.61%	-6.26%	-17.84%	-	-	-	34.09%	-14.64%	33.68%	-7.85%	46.06%	-6.24%	-38.28%	21.65%	-52.81%
Announcement Date	14/02/22	29/03/22	27/06/22	14/09/22	26/01/23	16/03/23	13/06/23	13/09/23	29/01/24	18/03/24	14/06/24	16/09/24	23/12/24	14/03/25	13/06/25	15/09/25	19/12/25	13/03/26	11/06/26	10/09/26	-

¹CAD in Million

Estimates

Fiscal Period: October	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt	-	-	-8.72	-5.54	4.5	-	-	-
Change	-	-	-	36.47%	181.23%	-	-	-
Announcement Date	14/02/22	26/01/23	29/01/24	23/12/24	19/12/25	-	-	-

Estimates

Fiscal Period: October	2021	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	0.2288	46.34	0.0993	-	-	-	-	-
Change	-	20,155.84%	-99.79%	-	-	-	-	-
Free Cash Flow (FCF) ¹	-7.073	-60.76	-30.44	-18.9	-10.91	-	-	-
Change	-	-759.14%	49.91%	37.92%	42.27%	100%	-	-
Announcement Date	14/02/22	26/01/23	29/01/24	23/12/24	19/12/25	-	-	-

¹CAD in Million

Estimates

Fiscal Period: October	2020	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-	-	-	-	-	-	-	-	-
EBIT Margin (%)	-	-	-	-	-	-	-	-476%	-14.79%
EBT Margin (%)	-	-	-	-	-	-	-	-556%	-16.35%
Net margin (%)	-	-	-	-	-	-	-	-556%	-16.35%
FCF margin (%)	-	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	101.54%	248.82%	78.05%	58.7%	69.29%	-	-	-
Profitability
ROA	-	-	-	-	-	-	-	-	-
ROE	-	-	-	-129.73%	-	-	-	-	112%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-0.31x	-	-	-
Debt / Free cash flow	-	-	-	-	-	-0.8x	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-3.43%	-190.6%	-0.25%	-	-	-	-	-
CAPEX / FCF (%)	-	-3.23%	-76.27%	-0.33%	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-0.1	-0.0616	-0.0332	-0.02	0.18	0.38
Change	-	-	-	-	38.4%	46.06%	39.81%	1,000%	111.11%
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	0.0413	-0.0398	-0.0764	-	-	-
Change	-	-	-	-	-196.37%	-91.93%	-	-	-
EPS ¹	-	-0.03	-0.09	-0.13	-0.1	-0.05	-0.025	-0.03	-0.05
Change	-	-	-200%	-44.44%	23.08%	50%	50%	-20%	-66.67%
Nbr of stocks (in thousands)	-	261,133	293,125	320,857	325,325	395,037	377,643	377,643	377,643
Announcement Date	-	14/02/22	26/01/23	29/01/24	23/12/24	19/12/25	-	-	-